CTCF and acute lymphoblastic leukemia: Our work in T-ALL found that gains in CTCF binding are located in distal enhancer regions, while cancer-specific CTCF binding loss events are enriched at gene promoter regions and correlate with repressed transcription of these promoters and decreased chromatin interactions.